ATOLIFE-F

Atorvastatin 10mg + Fenofibrate 160mg (in β-Cyclodextrin) is a potent lipid-lowering combination therapy used in the management of mixed dyslipidemia and high cholesterol levels. Atorvastatin, a statin, works by inhibiting HMG-CoA reductase to reduce the synthesis of cholesterol in the liver, thus lowering LDL cholesterol and triglycerides while increasing HDL levels. Fenofibrate, a fibrate, activates peroxisome proliferator-activated receptors (PPARs) to further decrease triglyceride levels and increase HDL. The inclusion of β-cyclodextrin enhances the solubility and bioavailability of Fenofibrate, making it more effective and better tolerated. This combination is ideal for patients with combined lipid disorders, especially those with elevated triglycerides and cardiovascular risk.